| T1 mapping by CMR imaging: from histological validation to clinical implication AA Kammerlander, BA Marzluf, C Zotter-Tufaro, S Aschauer, F Duca, ... JACC: Cardiovascular Imaging 9 (1), 14-23, 2016 | 200 | 2016 |
| The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics S Aschauer, AA Kammerlander, C Zotter‐Tufaro, R Ristl, S Pfaffenberger, ... European journal of heart failure 18 (1), 71-80, 2016 | 156 | 2016 |
| Interstitial fibrosis, functional status, and outcomes in heart failure with preserved ejection fraction: insights from a prospective cardiac magnetic resonance imaging study F Duca, AA Kammerlander, C Zotter-Tufaro, S Aschauer, ML Schwaiger, ... Circulation: cardiovascular imaging 9 (12), e005277, 2016 | 146 | 2016 |
| Gender-related differences in heart failure with preserved ejection fraction F Duca, C Zotter-Tufaro, AA Kammerlander, S Aschauer, C Binder, ... Scientific reports 8 (1), 1080, 2018 | 107 | 2018 |
| Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome C Nitsche, S Aschauer, AA Kammerlander, M Schneider, T Poschner, ... European Journal of Heart Failure 22 (10), 1852-1862, 2020 | 93 | 2020 |
| Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction D Dalos, J Mascherbauer, C Zotter-Tufaro, F Duca, AA Kammerlander, ... Journal of the American College of Cardiology 68 (2), 189-199, 2016 | 90 | 2016 |
| Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy P Garcia‐Pavia, F Bengel, D Brito, T Damy, F Duca, S Dorbala, ... European journal of heart failure 23 (6), 895-905, 2021 | 79 | 2021 |
| Wedge pressure rather than left ventricular end-diastolic pressure predicts outcome in heart failure with preserved ejection fraction J Mascherbauer, C Zotter-Tufaro, F Duca, C Binder, M Koschutnik, ... JACC: Heart Failure 5 (11), 795-801, 2017 | 77 | 2017 |
| Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation AA Kammerlander, M Wiesinger, F Duca, S Aschauer, C Binder, ... JACC: Cardiovascular Imaging 12 (8 Part 1), 1474-1483, 2019 | 71 | 2019 |
| Prognostic significance and determinants of the 6-min walk test in patients with heart failure and preserved ejection fraction C Zotter-Tufaro, J Mascherbauer, F Duca, B Koell, S Aschauer, ... JACC: Heart Failure 3 (6), 459-466, 2015 | 71 | 2015 |
| Modes of death in patients with heart failure and preserved ejection fraction S Aschauer, C Zotter-Tufaro, F Duca, A Kammerlander, D Dalos, ... International journal of cardiology 228, 422-426, 2017 | 56 | 2017 |
| Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved … G Karakus, AA Kammerlander, S Aschauer, BA Marzluf, C Zotter-Tufaro, ... Journal of Cardiovascular Magnetic Resonance 17 (1), 79, 2015 | 56 | 2015 |
| Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction G Goliasch, N Pavo, C Zotter‐Tufaro, A Kammerlander, F Duca, ... European Journal of Heart Failure 18 (1), 89-93, 2016 | 54 | 2016 |
| Presence of isolated tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction J Mascherbauer, AA Kammerlander, C Zotter-Tufaro, S Aschauer, F Duca, ... PloS one 12 (2), e0171542, 2017 | 50 | 2017 |
| Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy R Rettl, C Mann, F Duca, TM Dachs, C Binder, LC Ligios, L Schrutka, ... European Heart Journal-Cardiovascular Imaging 23 (6), 767-780, 2022 | 49 | 2022 |
| Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement D Bonderman, G Pölzl, K Ablasser, H Agis, S Aschauer, ... Wiener klinische Wochenschrift 132, 742-761, 2020 | 47 | 2020 |
| Feature tracking of global longitudinal strain by using cardiovascular MRI improves risk stratification in heart failure with preserved ejection fraction AA Kammerlander, C Donà, C Nitsche, M Koschutnik, R Schönbauer, ... Radiology 296 (2), 290-298, 2020 | 45 | 2020 |
| Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial TM Dachs, F Duca, R Rettl, C Binder-Rodriguez, D Dalos, LC Ligios, ... European heart journal 43 (36), 3402-3413, 2022 | 37 | 2022 |
| Outcome in heart failure with preserved ejection fraction: the role of myocardial structure and right ventricular performance G Goliasch, C Zotter-Tufaro, S Aschauer, F Duca, B Koell, ... PloS one 10 (7), e0134479, 2015 | 37 | 2015 |
| Mechanisms of heart failure in transthyretin vs. light chain amyloidosis C Binder, F Duca, PD Stelzer, C Nitsche, R Rettl, S Aschauer, ... European Heart Journal-Cardiovascular Imaging 20 (5), 512-524, 2019 | 36 | 2019 |
